MSB 3.21% $1.13 mesoblast limited

2023 The Final Countdown, page-54

  1. 4,194 Posts.
    lightbulb Created with Sketch. 5493
    10 days until approval window opens, FDA have booked the manufacturing facility inspection- something they did not do first time around. This is a good sign they have progressed forward further than last time, otherwise as the downrampers say they would have CRL'd and asked for another trial and not wasted time on a meaningless inspection.

    I hope the shorts continue increasing, and we get accelerated approval next month prior to any CR. That should send the SP rocketing. The more shorts, the mire buy pressure fuelling the rocket !
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.